Emotional Well-being and Measures of Healthy Aging

January 2, 2026 updated by: Judith Moskowitz, Northwestern University

Emotional Well-being and Biomarkers of Healthy Aging

This randomized control study is designed to understand the role of a positive psychology intervention (PARK: Positive Affect Regulation sKills) in biological aging and well-being. PARK provides a series of positive emotion skills in a self-guided online format, making the program accessible and convenient.

Our main aims are:

Aim 1: To explore the effects of PARK on psychological well-being (e.g., depression, anxiety, positive affect).

Aim 2: To explore the effects of PARK on biological age as defined by DNA methylation (DNAm) GrimAge and electrocardiogram-age (ECG-age), as well as physiological well-being in adults (e.g., cardiovascular, endocrine, musculoskeletal functioning, etc.).

Study Overview

Detailed Description

The skills in the Positive Psychology Intervention (PPI), PARK (e.g., gratitude, mindful awareness and nonjudgement, and self-compassion) are designed to promote positive emotion, which has been shown to provide resilience against stress. Positive emotion, independent of stress and negative emotion, has also been associated with a lower risk of mortality and better health behaviors such as likelihood of physical activity and healthy eating. This randomized control study will compare baseline well-being scores to post-online intervention at 3 months, 6 months, and 12 months post-baseline. Secondarily, measures of biological aging (DNAm GrimAge and ECG-age) and physiological functioning measures of cardiovascular, musculoskeletal, and endocrine functioning will be explored from baseline to post-intervention measures 3 and 12 months later.

Research will be based in Northwestern's Feinberg School of Medicine through the Potocsnak Human Longevity Lab and the Department of Medical Social Sciences (MSS), with all study procedures conducted in-person at the Human Longevity Lab or online. Eligibility screening, consent, and assessments will be conducted on REDCap. Consenting participants randomized to the treatment group will receive access to the online PARK platform within two weeks. The intervention consists of a positive skills course (including weekly lessons and daily skills practice) and daily emotion check-ins, hosted by BrightOutcome. The skills will be delivered over approximately 6 weeks, and individuals can participate from any device and location with internet access.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 40-70
  • Speaks and reads English
  • Able to access the online platform through their phone, a public device (i.e., at the library) or at home.
  • Lives in the Chicagoland area
  • Willing/able to travel to the Human Longevity Lab for in-person visits

Exclusion Criteria:

  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Prisoners
  • Vulnerable Populations
  • Pre-existing heart disease (prevalent coronary heart and cerebrovascular disease or heart failure)
  • Type 2 diabetes
  • Severe psychiatric illness

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Positive Emotion Skills Intervention
Participants will receive the 6-week online intervention, PARK (Positive Affect Regulation sKills Course).
Skills include positive events, capitalizing, gratitude, mindfulness, positive reappraisal, personal strengths, achievable goals, and self-compassion. The skills will be delivered over approximately 6 weeks, and individuals can participate from any device and location with internet access. A week will consist of 1-2 days of didactic material and 5-6 days of real-life skills practice and reporting. Participants cannot skip ahead and can only progress to the next lesson if they have completed the current one, but they can return to old lessons or exercises if they wish to.
No Intervention: Waitlist Control
The waitlist control condition will receive usual care in the Human Longevity Lab, which consists of a feedback report on biological age and lifestyle counseling from a clinical provider at the end of the study period. Control condition participants will have the option to gain access to the PARK platform and learn positive emotion skills after their study participation is completed at the end of 12 months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient-Reported Outcomes Measurement Information System (PROMIS) Positive Affect (v1.0) and PROMIS Meaning and Purpose (v1.0)
Time Frame: Baseline, 3 months, 6 months, 12 months
Computer Adaptive Testing measure of positive emotion and purpose. Higher scores mean a better outcome (i.e., more positive emotion). Scores can range from 9-85, and a t-score of 50 represents the mean score for the United States general population with a standard deviation of 10.
Baseline, 3 months, 6 months, 12 months
PROMIS Depression (v1.0), Anxiety (v1.0), Social Isolation (v2.0)
Time Frame: baseline and 3, 6, 12 months post-baseline

Computer Adaptive Testing measures of psychosocial well-being.

Higher scores mean a worse outcome (i.e., more anxiety or depression). Scores can range from 9-85, and a t-score of 50 represents the mean score for the United States general population with a standard deviation of 10.

baseline and 3, 6, 12 months post-baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Biological Age: DNA methylation GrimAge
Time Frame: Baseline, 3 months, 12 months
Biological age as defined by DNA methylation GrimAge, an estimation of biological age in units of years.
Baseline, 3 months, 12 months
ECG-age (electrocardiogram-age)
Time Frame: Baseline, 3 months, 12 months
Artificial intelligence algorithm using electrocardiogram data to estimate participant's age in unit of years. Higher ECG-age equates to greater cardiovascular aging.
Baseline, 3 months, 12 months
Telomere Length
Time Frame: Baseline, 3 months, 12 months
Telomere length measures cellular aging, measured in kilobases (kb). Longer telomere length indicates less cellular aging (a better outcome).
Baseline, 3 months, 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2025

Primary Completion (Estimated)

August 1, 2028

Study Completion (Estimated)

August 1, 2028

Study Registration Dates

First Submitted

December 8, 2025

First Submitted That Met QC Criteria

January 2, 2026

First Posted (Estimated)

January 12, 2026

Study Record Updates

Last Update Posted (Estimated)

January 12, 2026

Last Update Submitted That Met QC Criteria

January 2, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aging

Clinical Trials on Positive Emotion Skills Intervention

Subscribe